DE3016559A1 - Prostaglandinanaloge und diese enthaltende arzneimittel - Google Patents

Prostaglandinanaloge und diese enthaltende arzneimittel

Info

Publication number
DE3016559A1
DE3016559A1 DE19803016559 DE3016559A DE3016559A1 DE 3016559 A1 DE3016559 A1 DE 3016559A1 DE 19803016559 DE19803016559 DE 19803016559 DE 3016559 A DE3016559 A DE 3016559A DE 3016559 A1 DE3016559 A1 DE 3016559A1
Authority
DE
Germany
Prior art keywords
deep
radical
formula
radicals
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803016559
Other languages
German (de)
English (en)
Inventor
Gordon Leonard Bundy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE3016559A1 publication Critical patent/DE3016559A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19803016559 1979-05-01 1980-04-29 Prostaglandinanaloge und diese enthaltende arzneimittel Withdrawn DE3016559A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/035,144 US4220796A (en) 1979-05-01 1979-05-01 9-Deoxy-9-methylene-5,6-didehydro-PGF1 compounds

Publications (1)

Publication Number Publication Date
DE3016559A1 true DE3016559A1 (de) 1980-11-13

Family

ID=21880926

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803016559 Withdrawn DE3016559A1 (de) 1979-05-01 1980-04-29 Prostaglandinanaloge und diese enthaltende arzneimittel

Country Status (7)

Country Link
US (1) US4220796A (enExample)
JP (1) JPS55147256A (enExample)
BE (1) BE883071A (enExample)
DE (1) DE3016559A1 (enExample)
FR (1) FR2455579A1 (enExample)
GB (1) GB2048873B (enExample)
NL (1) NL8002356A (enExample)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016184A (en) 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4060534A (en) 1976-01-23 1977-11-29 The Upjohn Company 9-Deoxy-9-methylene-PGF compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165436A (en) * 1978-04-05 1979-08-21 The Upjohn Company Trans-2,3-didehydro-9-deoxy-9-methylene-PGF compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016184A (en) 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4060534A (en) 1976-01-23 1977-11-29 The Upjohn Company 9-Deoxy-9-methylene-PGF compounds

Also Published As

Publication number Publication date
NL8002356A (nl) 1980-11-04
BE883071A (fr) 1980-10-30
FR2455579A1 (fr) 1980-11-28
US4220796A (en) 1980-09-02
JPS55147256A (en) 1980-11-17
GB2048873A (en) 1980-12-17
FR2455579B1 (enExample) 1984-01-27
GB2048873B (en) 1983-05-25

Similar Documents

Publication Publication Date Title
DE3153474C2 (enExample)
CH648286A5 (de) Prostaglandinderivate, ihre herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE2154309B2 (de) 17-Phenyl-18,19,20-trinor-PGE2 und - PGF2 a und dieselben enthaltende Arzneimittel
CH628884A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga.
CH635072A5 (de) Prostaglandin-analoge.
DE2234709C2 (de) Prostanoesäurederivate und Verfahren zu deren Herstellung
CH628316A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit primaerer alkoholgruppe am c-1.
DE3016559A1 (de) Prostaglandinanaloge und diese enthaltende arzneimittel
DE2945781A1 (de) Prostacyclinzwischenprodukte und protacyclinanaloge
CH640847A5 (en) Process for preparing analogues of 5,6-dihydroprostacyclin
CH634297A5 (de) Prostaglandin-analoga.
DE2850212A1 (de) Prostacyclinanaloge
DE3016556A1 (de) Thromboxananaloge und thromboxanzwischenprodukte
DE2832372A1 (de) Prostaglandin-derivate, verfahren zu deren herstellung und endprodukte des herstellungsverfahrens
DE2121980C3 (de) Epimere 15-Methyl-15(S)- und 15-Me thyl- 15(R)-Prostansäurederi vate, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen
CH632252A5 (en) Process for preparing novel prostaglandin analogues
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine
DE3118849A1 (de) "isoxazolylderivate von 9(alpha),11(alpha)-epoxyimino-9,11,15-tridesoxy-pgf-artigen verbindungen
DE3146278C2 (de) cis-Bicyclo[3.3.0]octanderivate, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen
DE2344838A1 (de) Zwischenprodukte zur herstellung von 18-oxa-, 19-oxa-, 20-oxa- und 19-oxaomega-homo-prostaglandinen sowie verfahren zu deren herstellung
US4337203A (en) 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy PGF1 amides
US4328338A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-PGF1 amides
DE2830100A1 (de) Neue prostaglandinanaloge
DE1793690C3 (de) 1 S-Hydroxy-9-oxoprosta-5-cis-10,13trans-triensäure und deren Salze sowie Verfahren zu ihrer Herstellung
EP0051597A1 (de) Neue prostacyclinderivate und ihre herstellung.

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ

8141 Disposal/no request for examination